Ravensburg, Germany – Vetter Pharma-Fertigung, the leading expert for aseptic filling of liquid and lyophilized drugs, has received a manufacturing licence according to German drug law from the Tuebingen regional board for its new state-of-the-art plant, Ravensburg Vetter South.

After a planning and construction period of only three years and an investment of €100 million, one of the world’s most modern production facilities is now ready to begin work. Thanks to the highest possible level of automation and ultra-modern restricted access barrier system, Vetter can offer products of the highest quality. In addition to dual-chamber syringes and cartridges, the new location also enables the company to fill liquid or lyophilized vials, as well as single-chamber cartridges.

The new production lines are extremely flexible, making it possible to change systems and formats, including line clearance, cleaning and disinfection, much more quickly than with previous design concepts. With the new facility Vetter broadened its portfolio of services and expanded the capacity in the aseptic manufacturing by about 30%.